Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_pagePreview
Pharm-Olam Releases Updated Paper on the Impact of COVID on Clinical Research

Earlier this year, Pharm-Olam partnered with Informa’s Pharma Intelligence to draft a white paper that discusses the...


(1 minute read)

Tags: Infectious Disease & Vaccines, COVID-19, Global Coverage

6 Study Adaptations to Keep Studies Moving Despite COVID-19 Pandemic

The COVID-19 Pandemic continues to evolve and fluctuate across the globe – but not evenly or predictablySome countries have...


(22 minute read)

Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, Investigator Insights,

How Rave CSA Supports Remote Monitoring in COVID-19

In a world with COVID-19, remote monitoring is now essential to effectively monitor studies. Sponsors and CROs are either...


(2 minute read)

Tags: Pharm-Olam Insights, COVID-19

Conducting Clinical Trials in South Africa: A Revitalized Environment

South Africa was once a commonly considered country for inclusion in clinical research, but its popularity caused bottlenecks...


(4 minute read)

Tags: Pharm-Olam Insights, Global Coverage

The Future of Rare Disease Research

March was Rare Disease Month at Pharm-Olam. We started off by reviewing an article that was published in Nature (read it here...


(2 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Drug Repurposing in Rare Disease Research

Rare Disease Day may have been on 29 February, but at Pharm-Olam, we think it desires an entire month. Since the beginning of...


(3 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights

The Use of Gene Therapies in Rare Disease Research

At Pharm-Olam, March is Rare Disease Month. Over the past three weeks, we have been exploring the subject in greater detail....


(3 minute read)

Tags: Rare & Orphan Disease

The Use of Oligonucleotide Therapies in Rare Disease Research

Rare disease research is such a complicated area because it involves every therapeutic area individually and sometimes in...


(3 minute read)

Tags: Rare & Orphan Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover